Delivery Order SPE2DB24D2100-SPE2DB24FBBCS
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,185.88 firm fixed price delivery order is for the supply of 4,567,750,986 units of the drug Sorafenib 200 mg tablets. The contract has an ultimate completion date of April 1, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4,564,753,052 units of Sorafenib 200 mg tablets to the U.S. government. The contract, valued at $33,960.52, is a firm fixed-price delivery order with a period of performance through May 31, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the Department of Defense (DoD). Amerisourcebergen, a leading pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,272.22 firm fixed-price delivery order is for the provision of 120 tablets of the drug Sorafenib 200 mg. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
- This federal contract award, SPE2DB20D3103|SPE2DB25FN1T9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,603.82 firm fixed-price delivery order is for the supply of 4567678535 SORAFENIB 200 MG TABLET 120S. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sorafenib 200 mg tablets in quantities of 120 units, with a ceiling value of $28,126.60. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sorafenib 200 mg tablets (120-count) with a ceiling value of $45,892.39. This firm fixed-price delivery order, awarded on September 11, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sorafenib 200 mg tablets (120-count units) with a ceiling value of $14,770.22. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- This federal contract award, valued at $8,736.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXAVAR 200 MG TABLET 120S, a pharmaceutical product, with a performance period ending on February 14, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $10,685.92, is for the delivery of Inlyta 5 mg tablets. The contract has no set-aside designation, indicating full and open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,925.28 firm fixed-price delivery order is for the supply of 4,566,571,418 units of the pharmaceutical product Sunitinib Malate 25 mg capsules. The award has an ultimate completion date of December 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBBCSDelivery Order
This federal contract award, valued at $37,169.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of 120 tablets of Sorafenib 200 mg, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp is a division of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company is a leading provider of pharmaceutical products and medical supplies to various federal agencies, with a strong focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to efficiently procure essential medical commodities for military treatment programs and facilities globally. The contract does not have a set-aside designation, indicating that it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.2k | 4/24/24 |